| Ytd | -13.28% | |
| 1y | -14.26% |
| Open | 12.01 | Prev Close | 12.18 | Low | 12.06 | High | 12.18 | Mkt Cap | 10.15B |
| Vol | 328.65K | Avg Vol | 2.58M | EPS | 0.42 | P/E | 29.00 | Forward P/E | 18.72 |
| Beta | 0.29 | Short Ratio | 8.14 | Inst. Own | 15.86% | Dividend | 0.06 | Div Yield | 0.53 |
| Ex Div Date | 07-09 | Earning | 10-22 | 50-d Avg | 12.83 | 200-d Avg | 13.51 | 1yr Est | 13.49 |
RDY News
NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
NEW YORK, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
Dr. Reddy's (RDY) stock drops after missing Q1 FY27 earnings & revenue estimates. Semaglutid
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.06 per share which missed t
Companies Reporting Before The Bell • Northern Trust (NASDAQ:NTRS) is expected to report quarterly e
Dr Reddy's Laboratories (NYSE:RDY) released fourth-quarter financial results and hosted an earni
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, Inc. (Nasdaq: INVA), today announced that
The launch follows Dr. Reddy's receipt of the Notice of Compliance (NOC) from Health Canada on A
Dr. Reddy's launched generic Semaglutide Injection in Canada, expanding its GLP-1 portfolio and
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.03 per share which missed t
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:RDY, NSEIFSC: DRREDDY, along with
https://www.bloomberg.com/news/articles/2026-04-28/canada-approves-its-first-generic-version-of-novo
https://www.sec.gov/Archives/edgar/data/1135951/000157587226000247/rdy0885_6k.htm
India's drugmakers roll out low-cost copies for Novo Nordisk's semaglutide, slashing prices
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE:RDY, NSEIFSC: DRREDDY, along with
https://www.reuters.com/business/healthcare-pharmaceuticals/dr-reddys-aims-launch-generic-obesity-dr
Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage b
The Trump administration backs off plans to impose tariffs on generic drugs after internal debate ov
On Monday, 524 stocks hit new 52-week lows.
On Friday, 368 stocks hit new 52-week lows.
Wednesday's session saw 107 companies set new 52-week lows.
Before 10 a.m. ET Friday, 146 stocks hit new 52-week highs.
This morning 158 companies set new 52-week highs.
During Monday's morning session, 255 companies made new 52-week highs.
During Friday's morning session, 235 stocks hit new 52-week highs.
Companies Reporting Before The Bell • M/I Homes (NYSE:MHO) is estimated to report quarterly earn
Gainers Cassava Sciences, Inc. (NASDAQ: SAVA) shares jumped 34.6% to $9.54 following news of two
Before 10 a.m. ET Friday, 72 stocks made new 52-week highs.
Gainers Immutep Limited (NASDAQ: IMMP) rose 33.8% to $2.14 in pre-market trading after the compa
On Wednesday morning, 90 companies achieved new highs for the year.
During Monday's morning session, 179 stocks hit new 52-week highs.
During Tuesday's morning session, 138 companies made new 52-week highs.
During the morning session on Friday, 156 stocks hit new 52-week highs.
Thursday's morning session saw 73 companies set new 52-week highs.
This morning 97 companies reached new 52-week highs.
Companies Reporting Before The Bell • General Dynamics Inc. (NYSE:GD) is expected to report quarter
During Wednesday's morning session, 145 stocks hit new 52-week highs.
On Tuesday, 154 stocks made new 52-week highs.
On Wednesday morning, 30 companies achieved new highs for the year.
On Friday, 37 companies hit new 52-week highs.
During Tuesday's morning trading, 41 companies set new 52-week highs. Stocks that set new 52-wee
On Monday, these stocks hit new 52-week highs.
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Tuesday
Benzinga's Top Upgrades, Downgrades For January 28, 2020